HEADER CHAPERONE 29-SEP-20 7K9W TITLE CRYPTOCOCCUS NEOFORMANS HSP90 NUCLEOTIDE BINDING DOMAIN IN COMPLEX TITLE 2 WITH BUCMD00461 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HSP90-LIKE PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CRYPTOCOCCUS NEOFORMANS; SOURCE 3 ORGANISM_TAXID: 5207; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI 'BL21-GOLD(DE3)PLYSS AG'; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 866768 KEYWDS CRYPTOCOCCUS, HSP90, ATP-BINDING, INHIBITOR, CHAPERONE EXPDTA X-RAY DIFFRACTION AUTHOR D.A.KUNTZ,G.G.PRIVE REVDAT 3 18-OCT-23 7K9W 1 REMARK REVDAT 2 10-FEB-21 7K9W 1 JRNL REVDAT 1 27-JAN-21 7K9W 0 JRNL AUTH P.T.MARCYK,E.V.LEBLANC,D.A.KUNTZ,A.XUE,F.ORTIZ,R.TRILLES, JRNL AUTH 2 S.BENGTSON,T.M.G.KENNEY,D.S.HUANG,N.ROBBINS,N.S.WILLIAMS, JRNL AUTH 3 D.J.KRYSAN,G.G.PRIVE,L.WHITESELL,L.E.COWEN,L.E.BROWN JRNL TITL FUNGAL-SELECTIVE RESORCYLATE AMINOPYRAZOLE HSP90 INHIBITORS: JRNL TITL 2 OPTIMIZATION OF WHOLE-CELL ANTICRYPTOCOCCAL ACTIVITY AND JRNL TITL 3 INSIGHTS INTO THE STRUCTURAL ORIGINS OF CRYPTOCOCCAL JRNL TITL 4 SELECTIVITY. JRNL REF J.MED.CHEM. V. 64 1139 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 33444025 JRNL DOI 10.1021/ACS.JMEDCHEM.0C01777 REMARK 2 REMARK 2 RESOLUTION. 2.13 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.18.2_3874 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.13 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.48 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 27223 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.212 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.730 REMARK 3 FREE R VALUE TEST SET COUNT : 1015 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.4800 - 4.0800 1.00 3869 160 0.1621 0.1689 REMARK 3 2 4.0800 - 3.2400 1.00 3834 134 0.1852 0.2102 REMARK 3 3 3.2400 - 2.8300 1.00 3735 169 0.2063 0.2452 REMARK 3 4 2.8300 - 2.5700 1.00 3781 148 0.2163 0.2417 REMARK 3 5 2.5700 - 2.3900 1.00 3736 140 0.2277 0.2666 REMARK 3 6 2.3900 - 2.2500 1.00 3751 128 0.2444 0.2712 REMARK 3 7 2.2500 - 2.1300 0.94 3502 136 0.2583 0.3165 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.249 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.848 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 46.16 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.44 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 3380 REMARK 3 ANGLE : 0.813 4571 REMARK 3 CHIRALITY : 0.053 518 REMARK 3 PLANARITY : 0.004 580 REMARK 3 DIHEDRAL : 19.759 1229 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7K9W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-SEP-20. REMARK 100 THE DEPOSITION ID IS D_1000252124. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-FEB-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS-II REMARK 200 BEAMLINE : 17-ID-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97932 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27266 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.130 REMARK 200 RESOLUTION RANGE LOW (A) : 29.480 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : 0.03190 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.4700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.13 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.19 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.7 REMARK 200 DATA REDUNDANCY IN SHELL : 5.80 REMARK 200 R MERGE FOR SHELL (I) : 0.87100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6CJI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1 M LICL, 0.1 M HEPES OR CACODYLATE, REMARK 280 6.5 TO 7, 20-25% PEG 6K, 10-20% DMSO, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 72.75150 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 22.47650 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 72.75150 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 22.47650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -3 REMARK 465 PRO A -2 REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 THR A 3 REMARK 465 GLU A 4 REMARK 465 THR A 5 REMARK 465 LYS A 215 REMARK 465 GLY B -3 REMARK 465 PRO B -2 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 THR B 3 REMARK 465 GLU B 214 REMARK 465 LYS B 215 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 6 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 60 CD CE NZ REMARK 470 GLU A 71 CG CD OE1 OE2 REMARK 470 GLU A 160 CD OE1 OE2 REMARK 470 GLU A 163 CD OE1 OE2 REMARK 470 GLU A 179 CD OE1 OE2 REMARK 470 LYS A 195 CE NZ REMARK 470 GLU A 199 CG CD OE1 OE2 REMARK 470 PHE A 200 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU A 212 CG CD OE1 OE2 REMARK 470 THR A 213 OG1 CG2 REMARK 470 GLU A 214 C O CB CG CD OE1 OE2 REMARK 470 GLU B 4 CD OE1 OE2 REMARK 470 LYS B 27 CD CE NZ REMARK 470 LYS B 44 NZ REMARK 470 LYS B 60 CG CD CE NZ REMARK 470 GLU B 71 CD OE1 OE2 REMARK 470 LYS B 98 CG CD CE NZ REMARK 470 LYS B 102 CE NZ REMARK 470 ASP B 113 CG OD1 OD2 REMARK 470 GLU B 179 CD OE1 OE2 REMARK 470 LYS B 195 CD CE NZ REMARK 470 GLU B 212 CG CD OE1 OE2 REMARK 470 THR B 213 OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 59 115.63 -172.41 REMARK 500 SER A 198 34.99 -140.01 REMARK 500 GLU B 59 111.57 -176.01 REMARK 500 THR B 80 41.81 -107.70 REMARK 500 SER B 99 -42.96 -131.23 REMARK 500 PHE B 200 34.06 -95.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue W8S A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BEN A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue W8S B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BEN B 302 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7K9R RELATED DB: PDB REMARK 900 APO REMARK 900 RELATED ID: 7K9S RELATED DB: PDB REMARK 900 WITH NVP-AUY922 REMARK 900 RELATED ID: 7K9U RELATED DB: PDB REMARK 900 WITH BUCMD00429 REMARK 900 RELATED ID: 7K9V RELATED DB: PDB REMARK 900 WITH BUCMD00452 DBREF 7K9W A 1 215 UNP J9VVA4 J9VVA4_CRYNH 1 215 DBREF 7K9W B 1 215 UNP J9VVA4 J9VVA4_CRYNH 1 215 SEQADV 7K9W GLY A -3 UNP J9VVA4 EXPRESSION TAG SEQADV 7K9W PRO A -2 UNP J9VVA4 EXPRESSION TAG SEQADV 7K9W GLY A -1 UNP J9VVA4 EXPRESSION TAG SEQADV 7K9W SER A 0 UNP J9VVA4 EXPRESSION TAG SEQADV 7K9W GLY B -3 UNP J9VVA4 EXPRESSION TAG SEQADV 7K9W PRO B -2 UNP J9VVA4 EXPRESSION TAG SEQADV 7K9W GLY B -1 UNP J9VVA4 EXPRESSION TAG SEQADV 7K9W SER B 0 UNP J9VVA4 EXPRESSION TAG SEQRES 1 A 219 GLY PRO GLY SER MET SER THR GLU THR PHE GLY PHE GLN SEQRES 2 A 219 ALA GLU ILE SER GLN LEU LEU ASP LEU ILE ILE ASN THR SEQRES 3 A 219 PHE TYR SER ASN LYS GLU ILE PHE LEU ARG GLU LEU ILE SEQRES 4 A 219 SER ASN SER SER ASP ALA LEU ASP LYS ILE ARG TYR ALA SEQRES 5 A 219 ALA LEU THR ASP PRO SER GLN LEU ASP SER GLU LYS ASP SEQRES 6 A 219 LEU TYR ILE ARG ILE ILE PRO ASN LYS GLU GLU GLY THR SEQRES 7 A 219 LEU THR ILE ARG ASP THR GLY ILE GLY MET THR LYS ALA SEQRES 8 A 219 ASP LEU VAL ASN ASN LEU GLY THR ILE ALA LYS SER GLY SEQRES 9 A 219 THR LYS ALA PHE MET GLU ALA LEU SER SER GLY ALA ASP SEQRES 10 A 219 ILE SER MET ILE GLY GLN PHE GLY VAL GLY PHE TYR SER SEQRES 11 A 219 SER TYR LEU VAL ALA GLU LYS VAL GLN VAL THR THR LYS SEQRES 12 A 219 HIS ASN ASP ASP GLU GLN TYR ILE TRP GLU SER ALA ALA SEQRES 13 A 219 GLY GLY THR PHE THR ILE THR GLU ASP THR GLU GLY PRO SEQRES 14 A 219 ARG LEU GLY ARG GLY THR SER MET LYS LEU PHE ILE LYS SEQRES 15 A 219 GLU ASP LEU LYS GLU TYR LEU GLU GLU LYS ARG ILE ARG SEQRES 16 A 219 GLU ILE VAL LYS LYS HIS SER GLU PHE ILE SER TYR PRO SEQRES 17 A 219 ILE GLN LEU VAL VAL THR LYS GLU THR GLU LYS SEQRES 1 B 219 GLY PRO GLY SER MET SER THR GLU THR PHE GLY PHE GLN SEQRES 2 B 219 ALA GLU ILE SER GLN LEU LEU ASP LEU ILE ILE ASN THR SEQRES 3 B 219 PHE TYR SER ASN LYS GLU ILE PHE LEU ARG GLU LEU ILE SEQRES 4 B 219 SER ASN SER SER ASP ALA LEU ASP LYS ILE ARG TYR ALA SEQRES 5 B 219 ALA LEU THR ASP PRO SER GLN LEU ASP SER GLU LYS ASP SEQRES 6 B 219 LEU TYR ILE ARG ILE ILE PRO ASN LYS GLU GLU GLY THR SEQRES 7 B 219 LEU THR ILE ARG ASP THR GLY ILE GLY MET THR LYS ALA SEQRES 8 B 219 ASP LEU VAL ASN ASN LEU GLY THR ILE ALA LYS SER GLY SEQRES 9 B 219 THR LYS ALA PHE MET GLU ALA LEU SER SER GLY ALA ASP SEQRES 10 B 219 ILE SER MET ILE GLY GLN PHE GLY VAL GLY PHE TYR SER SEQRES 11 B 219 SER TYR LEU VAL ALA GLU LYS VAL GLN VAL THR THR LYS SEQRES 12 B 219 HIS ASN ASP ASP GLU GLN TYR ILE TRP GLU SER ALA ALA SEQRES 13 B 219 GLY GLY THR PHE THR ILE THR GLU ASP THR GLU GLY PRO SEQRES 14 B 219 ARG LEU GLY ARG GLY THR SER MET LYS LEU PHE ILE LYS SEQRES 15 B 219 GLU ASP LEU LYS GLU TYR LEU GLU GLU LYS ARG ILE ARG SEQRES 16 B 219 GLU ILE VAL LYS LYS HIS SER GLU PHE ILE SER TYR PRO SEQRES 17 B 219 ILE GLN LEU VAL VAL THR LYS GLU THR GLU LYS HET W8S A 301 34 HET BEN A 302 9 HET CL A 303 1 HET W8S B 301 34 HET BEN B 302 9 HETNAM W8S (1,3-DIHYDRO-2H-ISOINDOL-2-YL)(2,4-DIHYDROXY-6-{[3-(3- HETNAM 2 W8S METHOXYPHENYL)-1-METHYL-1H-PYRAZOL-5-YL]AMINO}PHENYL) HETNAM 3 W8S METHANONE HETNAM BEN BENZAMIDINE HETNAM CL CHLORIDE ION FORMUL 3 W8S 2(C26 H24 N4 O4) FORMUL 4 BEN 2(C7 H8 N2) FORMUL 5 CL CL 1- FORMUL 8 HOH *118(H2 O) HELIX 1 AA1 PHE A 8 TYR A 24 1 17 HELIX 2 AA2 GLU A 28 ASP A 52 1 25 HELIX 3 AA3 PRO A 53 ASP A 57 5 5 HELIX 4 AA4 THR A 85 GLY A 94 1 10 HELIX 5 AA5 GLY A 94 SER A 110 1 17 HELIX 6 AA6 MET A 116 GLY A 121 5 6 HELIX 7 AA7 VAL A 122 LEU A 129 5 8 HELIX 8 AA8 GLU A 179 LEU A 185 5 7 HELIX 9 AA9 GLU A 186 SER A 198 1 13 HELIX 10 AB1 THR B 5 TYR B 24 1 20 HELIX 11 AB2 GLU B 28 ASP B 52 1 25 HELIX 12 AB3 PRO B 53 ASP B 57 5 5 HELIX 13 AB4 THR B 85 SER B 99 1 15 HELIX 14 AB5 SER B 99 GLY B 111 1 13 HELIX 15 AB6 MET B 116 GLY B 121 5 6 HELIX 16 AB7 VAL B 122 LEU B 129 5 8 HELIX 17 AB8 GLU B 179 LEU B 185 5 7 HELIX 18 AB9 GLU B 186 SER B 198 1 13 SHEET 1 AA114 THR A 159 GLU A 160 0 SHEET 2 AA114 TYR A 146 SER A 150 -1 N ILE A 147 O THR A 159 SHEET 3 AA114 ALA A 131 LYS A 139 -1 N VAL A 136 O TRP A 148 SHEET 4 AA114 GLY A 170 ILE A 177 -1 O SER A 172 N THR A 137 SHEET 5 AA114 THR A 74 ASP A 79 -1 N LEU A 75 O LEU A 175 SHEET 6 AA114 ILE A 64 ASN A 69 -1 N ILE A 67 O THR A 76 SHEET 7 AA114 ILE A 205 THR A 210 1 O GLN A 206 N ILE A 64 SHEET 8 AA114 ILE B 205 THR B 210 -1 O VAL B 209 N LEU A 207 SHEET 9 AA114 ILE B 64 ASN B 69 1 N ILE B 64 O GLN B 206 SHEET 10 AA114 THR B 74 ASP B 79 -1 O ARG B 78 N ARG B 65 SHEET 11 AA114 GLY B 170 ILE B 177 -1 O LEU B 175 N LEU B 75 SHEET 12 AA114 ALA B 131 LYS B 139 -1 N LYS B 133 O PHE B 176 SHEET 13 AA114 GLN B 145 SER B 150 -1 O TRP B 148 N VAL B 136 SHEET 14 AA114 THR B 159 GLU B 160 -1 O THR B 159 N ILE B 147 SITE 1 AC1 17 ASN A 37 ASP A 40 ALA A 41 ASP A 79 SITE 2 AC1 17 ILE A 82 GLY A 83 MET A 84 ASN A 92 SITE 3 AC1 17 LEU A 93 ALA A 97 GLY A 121 TYR A 125 SITE 4 AC1 17 THR A 171 MET A 173 HOH A 430 HOH A 437 SITE 5 AC1 17 HOH A 447 SITE 1 AC2 2 ARG A 191 LYS B 211 SITE 1 AC3 2 PRO A 68 LYS A 70 SITE 1 AC4 17 ASN B 37 ASP B 40 ALA B 41 LYS B 44 SITE 2 AC4 17 ASP B 79 ILE B 82 MET B 84 ASN B 92 SITE 3 AC4 17 ILE B 96 PHE B 124 TRP B 148 SER B 150 SITE 4 AC4 17 THR B 171 MET B 173 HOH B 407 HOH B 419 SITE 5 AC4 17 HOH B 428 SITE 1 AC5 2 LYS A 211 ARG B 191 CRYST1 145.503 44.953 77.542 90.00 103.62 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006873 0.000000 0.001666 0.00000 SCALE2 0.000000 0.022245 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013270 0.00000